Skip Navigation LinksHome > April/June 2011 - Volume 33 - Issue 2 > An Update on Hereditary Angioedema
Advanced Emergency Nursing Journal:
doi: 10.1097/TME.0b013e318217b015
Cases of Note

An Update on Hereditary Angioedema

Verdi, Marylee BSN, RN; Shaker, Marcus MD, MS

Continued Education
Collapse Box


Hereditary angioedema affects approximately 1 in 50,000 individuals without gender or ethnic preference. Hereditary angioedema is caused by a decreased level (type I) or function (type II) of C1 inhibitor. Patients experience repeated episodes of angioedema involving sites that include the face, extremities, gastrointestinal tract, and larynx. Treatment involves measures to increase functioning levels of active C1 inhibitor through stimulation of endogenous pathways or exogenous supplementation. Additional therapies targeted at inhibition of bradykinin can also be used to treat episodes of angioedema. Treatment may be indicated for both acute episodes of angioedema and prevention of future episodes.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Tools

CE Test


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.